| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.003 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |